Does the media refer more to SBC or PSNL?

In the previous week, Personalis had 2 more articles in the media than SBC Medical Group. MarketBeat recorded 6 mentions for Personalis and 4 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 1.53 beat Personalis' score of 0.41 indicating that SBC Medical Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SBC Medical Group 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Personalis 1 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer OMDA or SBC?

In the previous week, Omada Health and Omada Health both had 4 articles in the media. SBC Medical Group's average media sentiment score of 1.53 beat Omada Health's score of 1.24 indicating that SBC Medical Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Omada Health 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SBC Medical Group 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media prefer SBC or LMRI?

In the previous week, SBC Medical Group and SBC Medical Group both had 4 articles in the media. SBC Medical Group's average media sentiment score of 1.53 beat Lumexa Imaging's score of 0.46 indicating that SBC Medical Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SBC Medical Group 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Lumexa Imaging 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer TALK or SBC?

In the previous week, Talkspace had 1 more articles in the media than SBC Medical Group. MarketBeat recorded 5 mentions for Talkspace and 4 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 1.53 beat Talkspace's score of 1.52 indicating that SBC Medical Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Talkspace 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SBC Medical Group 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media favor CSTL or SBC?

In the previous week, Castle Biosciences had 16 more articles in the media than SBC Medical Group. MarketBeat recorded 20 mentions for Castle Biosciences and 4 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 1.53 beat Castle Biosciences' score of 0.41 indicating that SBC Medical Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Castle Biosciences 8 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral SBC Medical Group 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

SBC Medical Group (SBC) Competitors

$3.14 +0.08 (+2.45%)

As of 11:09 AM Eastern

Compare

SBC vs. PSNL, OMDA, LMRI, TALK, and CSTL

Should you buy SBC Medical Group stock or one of its competitors? MarketBeat compares SBC Medical Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SBC Medical Group include Personalis (PSNL), Omada Health (OMDA), Lumexa Imaging (LMRI), Talkspace (TALK), and Castle Biosciences (CSTL).

How does SBC Medical Group compare to Personalis?

SBC Medical Group (NASDAQ:SBC) and Personalis (NASDAQ:PSNL) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, media sentiment, institutional ownership, earnings and profitability.

SBC Medical Group currently has a consensus target price of $8.50, suggesting a potential upside of 171.13%. Personalis has a consensus target price of $14.25, suggesting a potential upside of 8.07%. Given SBC Medical Group's stronger consensus rating and higher probable upside, research analysts clearly believe SBC Medical Group is more favorable than Personalis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SBC Medical Group	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Personalis	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22

60.8% of SBC Medical Group shares are held by institutional investors. Comparatively, 61.9% of Personalis shares are held by institutional investors. 81.7% of SBC Medical Group shares are held by company insiders. Comparatively, 4.2% of Personalis shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Personalis had 2 more articles in the media than SBC Medical Group. MarketBeat recorded 6 mentions for Personalis and 4 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 1.53 beat Personalis' score of 0.41 indicating that SBC Medical Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SBC Medical Group	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Personalis	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

SBC Medical Group has a net margin of 24.09% compared to Personalis' net margin of -148.11%. SBC Medical Group's return on equity of 15.90% beat Personalis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SBC Medical Group	24.09%	15.90%	11.61%
Personalis	-148.11%	-43.52%	-32.92%

SBC Medical Group has a beta of 0.6, meaning that its share price is 40% less volatile than the broader market. Comparatively, Personalis has a beta of 2.24, meaning that its share price is 124% more volatile than the broader market.

SBC Medical Group has higher revenue and earnings than Personalis. Personalis is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SBC Medical Group	$169.34M	1.90	$50.99M	$0.39	8.04
Personalis	$64.52M	21.40	-$81.27M	-$1.02	N/A

Summary

SBC Medical Group beats Personalis on 11 of the 16 factors compared between the two stocks.

How does SBC Medical Group compare to Omada Health?

Omada Health (NASDAQ:OMDA) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations, earnings and media sentiment.

Omada Health currently has a consensus target price of $24.75, indicating a potential upside of 21.48%. SBC Medical Group has a consensus target price of $8.50, indicating a potential upside of 171.13%. Given SBC Medical Group's higher probable upside, analysts clearly believe SBC Medical Group is more favorable than Omada Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omada Health	1 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.71
SBC Medical Group	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Omada Health has a beta of 1.73, meaning that its share price is 73% more volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.6, meaning that its share price is 40% less volatile than the broader market.

In the previous week, Omada Health and Omada Health both had 4 articles in the media. SBC Medical Group's average media sentiment score of 1.53 beat Omada Health's score of 1.24 indicating that SBC Medical Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Omada Health	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SBC Medical Group	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

SBC Medical Group has lower revenue, but higher earnings than Omada Health. Omada Health is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omada Health	$260.21M	4.65	-$12.78M	-$0.27	N/A
SBC Medical Group	$169.34M	1.90	$50.99M	$0.39	8.04

SBC Medical Group has a net margin of 24.09% compared to Omada Health's net margin of -2.22%. SBC Medical Group's return on equity of 15.90% beat Omada Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omada Health	-2.22%	-1.82%	-1.36%
SBC Medical Group	24.09%	15.90%	11.61%

60.8% of SBC Medical Group shares are owned by institutional investors. 6.4% of Omada Health shares are owned by insiders. Comparatively, 81.7% of SBC Medical Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

SBC Medical Group beats Omada Health on 10 of the 15 factors compared between the two stocks.

How does SBC Medical Group compare to Lumexa Imaging?

SBC Medical Group (NASDAQ:SBC) and Lumexa Imaging (NASDAQ:LMRI) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.

60.8% of SBC Medical Group shares are held by institutional investors. 81.7% of SBC Medical Group shares are held by company insiders. Comparatively, 0.7% of Lumexa Imaging shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

SBC Medical Group currently has a consensus price target of $8.50, suggesting a potential upside of 171.13%. Lumexa Imaging has a consensus price target of $16.00, suggesting a potential upside of 45.95%. Given SBC Medical Group's higher probable upside, research analysts plainly believe SBC Medical Group is more favorable than Lumexa Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SBC Medical Group	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

In the previous week, SBC Medical Group and SBC Medical Group both had 4 articles in the media. SBC Medical Group's average media sentiment score of 1.53 beat Lumexa Imaging's score of 0.46 indicating that SBC Medical Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SBC Medical Group	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Lumexa Imaging	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

SBC Medical Group has higher earnings, but lower revenue than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SBC Medical Group	$169.34M	1.90	$50.99M	$0.39	8.04
Lumexa Imaging	$1.03B	1.02	-$47.10M	-$0.59	N/A

SBC Medical Group has a net margin of 24.09% compared to Lumexa Imaging's net margin of 0.00%. SBC Medical Group's return on equity of 15.90% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SBC Medical Group	24.09%	15.90%	11.61%
Lumexa Imaging	N/A	N/A	N/A

Summary

SBC Medical Group beats Lumexa Imaging on 12 of the 15 factors compared between the two stocks.

How does SBC Medical Group compare to Talkspace?

Talkspace (NASDAQ:TALK) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.

Talkspace has a beta of 1.07, indicating that its stock price is 7% more volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.6, indicating that its stock price is 40% less volatile than the broader market.

In the previous week, Talkspace had 1 more articles in the media than SBC Medical Group. MarketBeat recorded 5 mentions for Talkspace and 4 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 1.53 beat Talkspace's score of 1.52 indicating that SBC Medical Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Talkspace	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
SBC Medical Group	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

SBC Medical Group has a net margin of 24.09% compared to Talkspace's net margin of 0.49%. SBC Medical Group's return on equity of 15.90% beat Talkspace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Talkspace	0.49%	1.03%	0.88%
SBC Medical Group	24.09%	15.90%	11.61%

57.4% of Talkspace shares are owned by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are owned by institutional investors. 23.5% of Talkspace shares are owned by insiders. Comparatively, 81.7% of SBC Medical Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Talkspace presently has a consensus price target of $5.56, indicating a potential upside of 6.66%. SBC Medical Group has a consensus price target of $8.50, indicating a potential upside of 171.13%. Given SBC Medical Group's stronger consensus rating and higher possible upside, analysts clearly believe SBC Medical Group is more favorable than Talkspace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Talkspace	1 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
SBC Medical Group	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

SBC Medical Group has lower revenue, but higher earnings than Talkspace. SBC Medical Group is trading at a lower price-to-earnings ratio than Talkspace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Talkspace	$238.37M	3.66	$7.79M	$0.01	521.50
SBC Medical Group	$169.34M	1.90	$50.99M	$0.39	8.04

Summary

SBC Medical Group beats Talkspace on 11 of the 16 factors compared between the two stocks.

How does SBC Medical Group compare to Castle Biosciences?

Castle Biosciences (NASDAQ:CSTL) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings.

92.6% of Castle Biosciences shares are owned by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are owned by institutional investors. 6.1% of Castle Biosciences shares are owned by insiders. Comparatively, 81.7% of SBC Medical Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Castle Biosciences had 16 more articles in the media than SBC Medical Group. MarketBeat recorded 20 mentions for Castle Biosciences and 4 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 1.53 beat Castle Biosciences' score of 0.41 indicating that SBC Medical Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Castle Biosciences	8 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
SBC Medical Group	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

SBC Medical Group has lower revenue, but higher earnings than Castle Biosciences. Castle Biosciences is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Castle Biosciences	$357.28M	2.51	-$24.16M	-$0.66	N/A
SBC Medical Group	$169.34M	1.90	$50.99M	$0.39	8.04

Castle Biosciences has a beta of 1, indicating that its stock price has a similar volatility profile to the broader market.Comparatively, SBC Medical Group has a beta of 0.6, indicating that its stock price is 40% less volatile than the broader market.

SBC Medical Group has a net margin of 24.09% compared to Castle Biosciences' net margin of -5.43%. SBC Medical Group's return on equity of 15.90% beat Castle Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Castle Biosciences	-5.43%	-4.15%	-3.45%
SBC Medical Group	24.09%	15.90%	11.61%

Castle Biosciences currently has a consensus target price of $42.00, suggesting a potential upside of 41.96%. SBC Medical Group has a consensus target price of $8.50, suggesting a potential upside of 171.13%. Given SBC Medical Group's higher probable upside, analysts plainly believe SBC Medical Group is more favorable than Castle Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Castle Biosciences	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.80
SBC Medical Group	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

SBC Medical Group beats Castle Biosciences on 9 of the 17 factors compared between the two stocks.

Get SBC Medical Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SBC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SBC vs. The Competition

Export

Metric	SBC Medical Group	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$321.58M	$9.92B	$6.79B	$12.63B
Dividend Yield	N/A	2.52%	2.59%	10.03%
P/E Ratio	8.04	25.56	282.14	25.05
Price / Sales	1.90	5.48	573.43	80.07
Price / Cash	5.85	26.24	28.60	46.71
Price / Book	1.22	5.21	11.09	6.19
Net Income	$50.99M	$311.05M	$3.49B	$347.61M
7 Day Performance	-1.72%	-0.45%	0.42%	0.74%
1 Month Performance	-3.54%	-1.16%	-4.33%	-3.72%
1 Year Performance	-25.00%	26.54%	63.09%	20.27%

SBC Medical Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SBC SBC Medical Group	3.5485 of 5 stars	$3.14 +2.5%	$8.50 +171.1%	-26.8%	$321.58M	$169.34M	8.04	N/A	News Coverage Positive News Short Interest Increase
PSNL Personalis	2.6033 of 5 stars	$11.63 -2.1%	$14.25 +22.5%	+134.9%	$1.22B	$69.65M	N/A	400	Upcoming Earnings
OMDA Omada Health	3.1945 of 5 stars	$20.41 -0.1%	$24.33 +19.2%	+14.2%	$1.21B	$283.30M	N/A	849	Analyst Forecast
LMRI Lumexa Imaging	4.2169 of 5 stars	$10.81 -1.5%	$16.00 +48.1%	N/A	$1.04B	$267.73M	N/A	5,019
TALK Talkspace	3.3781 of 5 stars	$5.23 +0.3%	$5.56 +6.5%	+126.0%	$875.24M	$228.87M	523.02	500	Positive News Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SBC) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SBC Medical Group (SBC) Competitors

SBC vs. PSNL, OMDA, LMRI, TALK, and CSTL

How does SBC Medical Group compare to Personalis?

Summary

How does SBC Medical Group compare to Omada Health?

Summary

How does SBC Medical Group compare to Lumexa Imaging?

Summary

How does SBC Medical Group compare to Talkspace?

Summary

How does SBC Medical Group compare to Castle Biosciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SBC vs. The Competition

SBC Medical Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

SBC Medical Group (SBC) Competitors

SBC vs. PSNL, OMDA, LMRI, TALK, and CSTL

How does SBC Medical Group compare to Personalis?

Do analysts prefer SBC or PSNL?

Do institutionals & insiders hold more shares of SBC or PSNL?

Does the media refer more to SBC or PSNL?

Is SBC or PSNL more profitable?

Which has more risk & volatility, SBC or PSNL?

Which has better earnings & valuation, SBC or PSNL?

Summary

How does SBC Medical Group compare to Omada Health?

Do analysts prefer OMDA or SBC?

Which has more risk and volatility, OMDA or SBC?

Does the media prefer OMDA or SBC?

Which has preferable earnings & valuation, OMDA or SBC?

Is OMDA or SBC more profitable?

Do institutionals and insiders believe in OMDA or SBC?

Summary

How does SBC Medical Group compare to Lumexa Imaging?

Do institutionals & insiders hold more shares of SBC or LMRI?

Do analysts prefer SBC or LMRI?

Does the media prefer SBC or LMRI?

Which has higher earnings & valuation, SBC or LMRI?

Is SBC or LMRI more profitable?

Summary

How does SBC Medical Group compare to Talkspace?

Which has more volatility & risk, TALK or SBC?

Does the media prefer TALK or SBC?

Is TALK or SBC more profitable?

Do insiders and institutionals believe in TALK or SBC?

Do analysts recommend TALK or SBC?

Which has better valuation & earnings, TALK or SBC?

Summary

How does SBC Medical Group compare to Castle Biosciences?

Do insiders & institutionals hold more shares of CSTL or SBC?

Does the media favor CSTL or SBC?

Which has stronger valuation and earnings, CSTL or SBC?

Which has more risk & volatility, CSTL or SBC?

Is CSTL or SBC more profitable?

Do analysts prefer CSTL or SBC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SBC vs. The Competition

SBC Medical Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools